SUPRIYA Supriya Lifescience Ltd Expansion Plans Announcement 2024 - Global Expansion Supriya Lifescience Ltd has received approval for Esketamine Hydrochloride from Brazil's health authority ANVISA and filed a patent for a low-cost production method of Atorvastatin, aiming to enhance drug affordability and expand in LATAM markets..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Supriya Lifescience Ltd